证券代码：688531 证券简称：日联科技 公告编号：2025-060 日联科技集团股份有限公司 2025年第二次临时股东会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、会议召开和出席情况 | 1、出席会议的股东和代理人人数 | 181 | | --- | --- | | 普通股股东人数 | 181 | | 2、出席会议的股东所持有的表决权数量 | 71,009,264 | | 普通股股东所持有表决权数量 | 71,009,264 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比例（%） | 43.1632 | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 43.1632 | （四）表决方式是否符合《公司法》及公司章程的规定，大会主持情况等。 1、公司在任董事7人，出席7人； 2、公司在任监事3人，出席3人； 3、董事会秘书辛晨先生出席了本次会议；其他高管列席了本次会议。 二、议案审议情况 （一）非累积投票议案 1、 议案名称：《关 ...

国浩律师（南京）事务所 关 于 日联科技集团股份有限公司 2025 年第二次临时股东会 之 法律意见书 南京市汉中门大街 309 号 B 座 5/7/8 层 邮编：210036 5,7,8th Floor, Block B, 309 Hanzhongmen Street, Nanjing 210036, China 电话/Tel: +86 25 8966 0900 传真/Fax: +86 25 8966 0966 网址/Website: http://www.grandall.com.cn 2025 年 9 月 国浩律师(南京)事务所 法律意见书 目 录 | 关于本次股东会的召集、召开程序 . | 2 | | --- | --- | | i í | 关于本次股东会出席人员的资格和召集人资格 . | | 11 Í | 关于本次股东会的表决程序及表决结果 | | 四、 结论意见 . | | | 签署页 | | 一、 关于本次股东会的召集、召开程序 l 国浩律师(南京)事务所 法律意见书 国浩律师（南京）事务所 关于日联科技集团股份有限公司 2025年第二次临时股东会之法律意见书 致：日联科技集团股份有限公司 根据 ...

Group 1 - The stock price of Rilun Technology (688531.SH) fell by 3.93% to 55.96 yuan as of the market close on September 12, 2023 [1] - Rilun Technology was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on March 31, 2023, with an initial public offering (IPO) of 19.851367 million shares at a price of 152.38 yuan per share [1] - The highest price recorded for Rilun Technology since its listing was 241.11 yuan on the first trading day, indicating the stock is currently in a state of decline [1] Group 2 - The total funds raised from the IPO amounted to 302.49513 million yuan, with a net amount of 273.07907 million yuan, exceeding the original plan by 213.07907 million yuan [1] - The company planned to use the raised funds for projects including X-ray source industrialization, construction of an X-ray detection equipment production base in Chongqing, R&D center establishment, and working capital [1] - The total issuance costs for the IPO were 29.41606 million yuan (excluding tax), with underwriting fees accounting for 26.17879 million yuan [1] Group 3 - Rilun Technology announced a dividend plan on May 31, 2024, proposing a stock bonus of 4.5 shares for every 10 shares held, along with a pre-tax cash dividend of 8 yuan [3] - Another dividend plan was released on July 4, 2025, proposing a similar stock bonus of 4.5 shares for every 10 shares held, but with a reduced pre-tax cash dividend of 6 yuan [4]

作为国内工业X射线检测领域的龙头企业，日联科技已经构建起"核心部件+AI软件算法+检测设备"全产 业链技术壁垒。未来日联科技计划建立全球最大规模的工业X射线影像算力中心，继续引领工业智能检 测产业发展。 "最开始进入AI领域，其实是因为基于客户的需求，我们就把AI算法引入了这个领域，AI算法在做工业 X射线图像分析的时候，它的效果要比传统方法要好得多，速度也更快。所以我们就逐渐把AI重点和我 们的设备、整个场景进行了很好的结合。未来，我们期望用最前沿的人工智能算法，把我们的设备升级 成一款智能检测的智能体。"日联研究院副院长孔海洋说道。 转自：无锡博报 人工智能是新一轮科技革命和产业变革的重要驱动力量。今年以来，无锡密集发布建设"人工智能+"标 杆城市的"1+2+3"系列文件，重点提出以人工智能推动新型工业化，培育发展新质生产力。 人工智能"一子落"，带动新质生产力发展"满盘活"。如今在无锡，"AI+智能装备""AI+自动驾驶"等战略 性新兴产业发展如火如荼，"AI+工业"成果迭出。 无锡羚数人工智能科技有限公司董事长总经理郭文蔚表示，在不同的制造业领域当中，工业垂类模型能 够帮助企业去赋能很多具体的操作环节 ...

证券代码：688531 证券简称：日联科技 日联科技集团股份有限公司 2025 年第二次临时股东会会议材料 日联科技集团股份有限公司 2025 年第二次临时股东会会议材料 2025 年 9 月 1 | | | 日联科技集团股份有限公司 2025 年第二次临时股东会会议须知 为维护全体股东的合法权益，确保股东会会议秩序和议事效率，保证股东会 的顺利召开，根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公 司股东会规则》以及《日联科技集团股份有限公司章程》（以下简称"《公司章程》"） 和日联科技集团股份有限公司（以下简称"公司"）有关规定，特制定 2025 年第 二次临时股东会会议须知： 一、为确认出席会议的股东或其代理人或其他出席者的出席资格，会议工作 人员将对出席会议者的身份进行必要的核对工作，请被核对者给予配合。 二、出席会议的股东及股东代理人须在会议召开前 30 分钟到会议现场办理 签到手续，并请按规定出示证券账户卡、身份证明文件或法人单位证明、授权委 托书等，经验证后领取会议资料，方可出席会议。会议开始后，由会议主持人宣 布现场出席会议的股东人数及其所持有表决权的股份总数，在此之后进场的股东 ...

Core Insights - The presentation by Kong Haiyang at the CSEAC 2025 highlighted the significance of micro-focus/nano-focus X-ray sources as the "heart" of X-ray intelligent detection equipment, determining performance ceilings and key metrics such as spatial resolution, penetration capability, and imaging stability [2] - Relying on breakthroughs in X-ray source technology, the company has achieved comprehensive coverage of various types of X-ray sources, becoming the only domestic enterprise to cover the entire chain from theoretical foundations to reliability verification and large-scale industrialization [2] - The integration of AI algorithms into X-ray detection equipment has significantly enhanced detection efficiency and precision, with the company establishing an AI-driven closed loop of data, algorithms, and computing power in industrial X-ray detection [3] Company Developments - The company has developed a range of X-ray sources covering voltages from 90kV to 150kV, with breakthroughs in open-tube X-ray sources achieving capabilities at the nanometer level [2] - The company aims to transition from a high-end intelligent detection equipment manufacturer to an AI-driven industrial intelligent detection solution provider, leveraging rich customer resources and deep technological reserves in AI [3] - The company emphasizes the need for collaboration within the semiconductor detection equipment industry to progress from following to leading in the global market [3]

Investment Rating - The report indicates a positive outlook for the thermal management materials industry, driven by strong downstream market demand and technological advancements [3][21]. Core Insights - The thermal management materials industry is experiencing sustained growth due to increasing demand from downstream sectors such as consumer electronics, automotive electronics, and data centers. The global thermal management market is projected to grow at a compound annual growth rate (CAGR) of 8.5%, increasing from $17.3 billion in 2023 to $26.1 billion by 2028 [3][21]. - The penetration rates of heat pipes and vapor chambers are continuously rising, with local procurement becoming a significant trend as domestic companies mature technologically [3][21]. Summary by Sections 1. Industry Demand and Growth - The global demand for thermal management materials is on the rise, with a forecasted market size growth from $17.3 billion in 2023 to $26.1 billion by 2028, reflecting a CAGR of 8.5% [3][21]. - The shift towards high-performance, miniaturized, and integrated electronic products is intensifying the need for effective thermal management solutions [3][21]. 2. Market Segmentation - Heat pipes and vapor chambers are becoming mainstream solutions in high-end smartphones, with market sizes expected to reach $3.776 billion and $1.197 billion respectively by 2025, with CAGRs of 6.17% and 14.20% [15][18]. - The thermal interface materials market is projected to grow from $5.2 billion in 2019 to $7.6 billion by 2026, with a CAGR of 5.57% [16][19]. 3. Local Procurement Trends - Local procurement is becoming a dominant trend in the thermal management materials industry, driven by supply chain security concerns among domestic electronic brands [35][36]. - Domestic companies like Suzhou Tianmai and Zhongshi Technology are expected to benefit from this trend as they enhance their technological capabilities [35][36]. 4. Key Beneficiaries - Suzhou Tianmai is highlighted as a key player in the industry, having established itself early in the ultra-thin heat pipe and vapor chamber market, achieving significant production scale and client certifications [4][35].

9月5日，日联科技涨5.07%，截至发稿，报59.68元/股，成交1.61亿元，换手率2.56%，总市值98.83亿 元。 金鹰元和混合A（002681）成立日期2016年5月25日，最新规模5149.35万。今年以来收益15.85%，同类 排名3887/8178；近一年收益33.98%，同类排名3741/7978；成立以来收益115.04%。 金鹰元和混合A（002681）基金经理为倪超。 截至发稿，倪超累计任职时间10年90天，现任基金资产总规模30.16亿元，任职期间最佳基金回报 156.51%， 任职期间最差基金回报-21.21%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 资料显示，日联科技集团股份有限公司位于江苏省无锡市新吴区漓江路11号，成立日期2009年7月22 日，上市日期2023年3月31日，公司主营业务涉及公司是国内领先的工业X射线智能检测装备供应商,主 要从事微焦点和大功率X射线智能检测装备的研发、生产、销售与服务,产品和 ...

Core Insights - The demand for high-precision inspection in China is significantly increasing due to advancements in industrial manufacturing, particularly in semiconductor, electronic manufacturing, and new energy battery sectors [1][5] - The market size for China's industrial micro-focus X-ray source industry is projected to reach 1.58 billion yuan in 2024, representing a year-on-year growth of 29.51% [1][5] - The global market size for industrial micro-focus X-ray sources is expected to reach 736 million USD in 2024, with a year-on-year growth of 21.71% [5] Industry Overview - Industrial micro-focus X-ray sources are high-precision X-ray emission devices characterized by extremely small focal sizes (typically at the micron level), capable of producing high-energy, high-resolution X-ray beams for precise internal structure inspection [2][3] - The industry is categorized into open tube and closed tube micro-focus X-ray sources based on sealing technology [2] Industry Value Chain - The upstream of the industrial micro-focus X-ray source industry includes raw materials and components such as vacuum glass, ceramic electrodes, reflective target materials, and X-ray tubes [2] - The midstream involves the production and manufacturing of industrial micro-focus X-ray source equipment [2] - The downstream applications include integrated circuits, electronic manufacturing, new energy batteries, and industrial inspection [2] Market Size - The industrial micro-focus X-ray source market is expanding due to the increasing demand for high-precision inspection in semiconductor and electronic manufacturing [5] - The market size for the non-destructive testing industry in China is projected to reach 19 billion yuan in 2024, with a year-on-year growth of 2.15% [3] Key Companies - Dayun Technology (日联科技) has made significant advancements in the field of industrial micro-focus X-ray sources, achieving breakthroughs in technology and product quality, and has established a vertical integration model covering the entire spectrum of X-ray sources [6][7] - Dayun Technology reported a revenue of 200 million yuan in Q1 2025, reflecting a year-on-year growth of 33.19% [7] - Dandong Aolong Ray Instrument Group focuses on the development and production of industrial X-ray detection equipment and has a strong technical foundation in micro-focus X-ray sources [8] Industry Development Trends 1. The industry is accelerating towards 3D/CT technology to enhance defect identification capabilities, particularly in semiconductor packaging and new energy battery manufacturing [9] 2. There is a shift towards online automation to meet modern manufacturing demands for efficient production and quality control, enabling real-time monitoring and reducing manual intervention [10] 3. The integration of artificial intelligence and big data technologies is driving the industry towards AI intelligence, enhancing detection efficiency and accuracy through automated defect recognition [10]

Core Viewpoint - The article discusses the upcoming 2025 Shanghai Leading Industries and the 14th Pharmaceutical CEO Forum, highlighting the focus on innovation and global expansion of Chinese pharmaceutical companies [1]. Summary by Sections Event Overview - The event will take place on September 4-5, 2025, at the Mandarin Oriental Hotel in Pudong, Shanghai, featuring nearly a hundred executives from listed companies, including chairpersons, CEOs, and industry leaders [4]. Morning Sessions - The morning session on September 4 will include a keynote speech and several roundtable discussions focusing on topics such as the global expansion of Chinese pharmaceutical companies and the search for the next billion-dollar drug [4][5]. - Notable discussions will include: - "From Local Innovation to Global Leadership: The Era of Chinese Pharmaceutical Companies Going Abroad" [4]. - "The Birth of Big Drugs is the Future of Pharmaceuticals: Finding the Next Billion-Dollar Bomb" [4]. Afternoon Sessions - The afternoon will feature discussions on future disease areas and technologies worth exploring for pharmaceutical assets going abroad, as well as the new cycle of Chinese innovative drugs under global competition [5][6]. - Additional topics will cover advancements in drug development platforms and the emerging field of brain-machine interfaces [6]. TMT Forum - The TMT (Technology, Media, and Telecommunications) forum will also take place, discussing AI's impact on various industries, including gaming and healthcare [7][8]. - Key topics will include AI innovations in mobile internet ecosystems and the future of AI in healthcare [7]. Pharmaceutical Sub-Forum - The pharmaceutical sub-forum will address topics such as ADC technology exploration, probiotic delivery systems, and the future development paths of dual antibodies and XDC [8]. - Discussions will also focus on the integration of medical insurance and the innovative practices in building a multi-level medical security system in China [8].